West Pharmaceutical Services, I Price Today
West Pharmaceutical Services, I
WST
Healthcare
$23.74B
💰
Market Cap
43.3
💸
Price to Earnings
$7.4
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
5 |
Strong Buy |
4 |
Hold |
4 |
Sell |
0 |
Strong Sell |
0 |
WST Price Forecast Target
320.9 👉 460.0 +43%
WST EPS Forecast
7.4 👉 8.8 +19%
Financials
Profit Margin
19 %
Revenue Growth
8.8 %
Dividend
$ 0.8
Held Percent
0.5% - Insiders
96.2% - Institutions
3.3% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $3.4B
-
💰 Blackrock Inc. $3.0B
-
💰 Bank Of New York Mellon Corporation $1.3B
-
💰 State Street Corporation $1.3B
-
💰 Price (T.Rowe) Associates Inc $1.1B
Stock Ideas
Carl Icahn Portfolio
With a staggering net worth exceeding $16 billion, Icahn has made a lasting impact on the stock market as the founder and manager of Icahn Enterprises. Known as a 'corporate raider,' Icahn has gained fame for his relentless pursuit of undervalued co…
Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investment…
Chase Coleman Portfolio
Chase Coleman, the young and accomplished founder of Tiger Global, has made a significant impact in the investment world. With initial funding from Julian Robertson, Coleman's Tiger Global Management delivered impressive returns, including a remarka…
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…📮FAQ
Some Frequently Asked Questions.
The West Pharmaceutical Services, I industry is Medical Instruments & Supplies
The West Pharmaceutical Services, I sector is Healthcare
The West Pharmaceutical Services, I forecasted predicted Price to Earnings PE ratio is 36.3
The West Pharmaceutical Services, I Price to Earnings PE ratio is 43.3
The Market Capitalization of West Pharmaceutical Services, I is $23.74B
There are total of 73573108 float shares with 96.2% held by Institutions and 0.5% held by insiders
The MWest Pharmaceutical Services, I forecasted Earnings per Share EPS is $8.8
The West Pharmaceutical Services, I Earnings per Share EPS is 7.4
The West Pharmaceutical Services, I company has $1136200000 gross profits with 19 profit margins
The West Pharmaceutical Services, I Earnings Growth is 0.346% with 0.337% quarterly earnings growth
The West Pharmaceutical Services, I Revenue is $2926500096 with 0.088 revenue growth
The price target for West Pharmaceutical Services, I stock is $460.0 for the high target and $325.0 for the low target
The consensus analyst recommendations for West Pharmaceutical Services, I is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for West Pharmaceutical Services, I is Buy, with the following breakdown:
- Buy: 5
- Strong Buy: 4
- Hold: 4
- Sell: 0
- Strong Sell: 0
The Beta of West Pharmaceutical Services, I is 1.1
The dividend of West Pharmaceutical Services, I is $0.8
The dividend yield of West Pharmaceutical Services, I is 0.0025%
The biggest institutional and mutual fund holders of West Pharmaceutical Services, I stock are
- Vanguard Group Inc
- Blackrock Inc.
- Bank Of New York Mellon Corporation
- State Street Corporation
The West Pharmaceutical Services, I ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0